Pjase I study of peptide vacicination using eitope petide derived from novel oncoantigen for patients with metastatic or recuurent cholangiocarcinoma
Phase 1
- Conditions
- cholangiocarcinoma
- Registration Number
- JPRN-UMIN000004660
- Lead Sponsor
- Department of Surgical Oncology, Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1.severe ischemic heart disease and arrythmia 2. pregnant woman 4. severe active infection disease 5. pateients required administration of steroids 6.multiple cancer patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of safety of peptide vaccine and gemcitabine
- Secondary Outcome Measures
Name Time Method Immunological Response, Respoense rate